Human Craniomaxillofacial Allotransplantation
Sponsor: Johns Hopkins University
Listed as NCT01889381, this PHASE2 trial focuses on Craniofacial Defects and Craniofacial Injuries and remains actively recruiting participants. Sponsored by Johns Hopkins University, it has been updated 14 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Sep 2023 — Jul 2024 [monthly]
Recruiting PHASE2
-
Sep 2022 — Sep 2023 [monthly]
Recruiting PHASE2
▶ Show 9 earlier versions
-
Sep 2021 — Sep 2022 [monthly]
Recruiting PHASE2
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE2
-
May 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Aug 2019 — May 2020 [monthly]
Recruiting PHASE2
-
May 2019 — Aug 2019 [monthly]
Recruiting PHASE2
-
Nov 2018 — May 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE2
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Oct 2017 [monthly]
Recruiting PHASE2
First recorded
Aug 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Johns Hopkins University
For direct contact, visit the study record on ClinicalTrials.gov .